Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
5200 participants
INTERVENTIONAL
2024-10-15
2025-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* will outreach via text or patient portal message result in more parents having access than usual care (which is in-office suggestions to get access).
* which mode - text or portal - will get more parents access. Participants will get a text message, or a portal message through their own patient portal, or no message. The investigators will check access to see which group has increased more during the study period.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Optimizing Strategies to Maximize Patient Recruitment Yield
NCT07290335
UCLA Health Patient Health Maintenance Outreach Text Message
NCT05793788
Effect of Varied Outreach Methods on Appointment Scheduling and Appointment Completion Using MyChart
NCT04994691
Teen-to-Teen Videos to Improve Electronic Medical Record Portal Knowledge and Personal Health Information Engagement
NCT06096987
Final Prototype Refinement of Adaptive Cell Phone Support
NCT07084155
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A secondary objective of the study is to compare messaging strategies, with one arm being a message to the guardian's patient portal, and the other text messaging.
Another secondary objective of the study is to ascertain whether sending information about activation to a guardian via text or email (as preferred) will result in self-activating their own Electronic Health Record (EHR) patient portal access.
At the conclusion of the study, the investigators will determine best-method for activation and utilize this method to invite guardians initially randomized to the usual-care arm of the study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Usual Care
Care as usual
No interventions assigned to this group
Preferred Modality
Text or email message to guardian with proxy information. If the guardian has no personal MyChart access, before sending proxy information to set up access to their child's MyChart, the investigators will message the guardian up to two times with information enabling them to access their personal MyChart.
Email message sent to guardian with proxy information.
Text
Text message sent to guardian with proxy information.
Patient Portal
Patient portal message (MyChart) to guardian with proxy information. If the guardian has no personal MyChart access, before sending proxy information to set up access to their child's MyChart, the investigators will message the guardian up to two times with information enabling them to access their personal MyChart.
Patient Portal Message
Patient portal message (MyChart) to guardian with proxy information.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Email message sent to guardian with proxy information.
Text
Text message sent to guardian with proxy information.
Patient Portal Message
Patient portal message (MyChart) to guardian with proxy information.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Guardians with EHR proxy access already activated for all children in their care.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Yale University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ada Fenick, MD
Role: PRINCIPAL_INVESTIGATOR
Yale University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cornell Scott Hill Health Center
New Haven, Connecticut, United States
Fair Haven Community Health Center
New Haven, Connecticut, United States
Yale New Haven Health
New Haven, Connecticut, United States
Yale School of Medicine
New Haven, Connecticut, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
000
Identifier Type: OTHER
Identifier Source: secondary_id
2000034372
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.